Ju-ock Kim

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Targeting YAP-p62 signaling axis suppresses the EGFR-TKI-resistant lung adenocarcinoma.

Targeting YAP-p62 signaling axis suppresses the EGFR-TKI-resistant lung adenocarcinoma.

Journal: Cancer medicine

Published: September 04, 2020

Secondary infection among hospitalized COVID-19 patients: A retrospective cohort study in a tertiary care setting.

Secondary infection among hospitalized COVID-19 patients: A retrospective cohort study in a tertiary care setting.

Journal: Respirology (Carlton, Vic.)

Published: August 13, 2020

Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.

Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.

Journal: BMC cancer

Published: July 30, 2019

Pleural or pericardial metastasis: A significant factor affecting efficacy and adverse events in lung cancer patients treated with PD-1/PD-L1 inhibitors.

Pleural or pericardial metastasis: A significant factor affecting efficacy and adverse events in lung cancer patients treated with PD-1/PD-L1 inhibitors.

Journal: Thoracic cancer

Published: July 26, 2018

Effect of Exposure to Second-Hand Smoke on the Quality of Life: A Nationwide Population-Based Study from South Korea.

Effect of Exposure to Second-Hand Smoke on the Quality of Life: A Nationwide Population-Based Study from South Korea.

Journal: PloS one

Published: July 08, 2015

Ethics in the Intensive Care Unit.

Ethics in the Intensive Care Unit.

Journal: Tuberculosis and respiratory diseases

Published: February 02, 2015

Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer.

Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer.

Journal: Thoracic cancer

Published: September 05, 2014

Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis.

Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis.

Journal: Respirology (Carlton, Vic.)

Published: July 30, 2014

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy.

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy.

Journal: Tuberculosis and respiratory diseases

Published: July 16, 2014

Effects of Lobetyolin, Lobetyol and Methyl linoleate on Secretion, Production and Gene Expression of MUC5AC Mucin from Airway Epithelial Cells.

Effects of Lobetyolin, Lobetyol and Methyl linoleate on Secretion, Production and Gene Expression of MUC5AC Mucin from Airway Epithelial Cells.

Journal: Tuberculosis and respiratory diseases

Published: June 01, 2014

Effects of Morus alba L. and Natural Products Including Morusin on In Vivo Secretion and In Vitro Production of Airway MUC5AC Mucin.

Effects of Morus alba L. and Natural Products Including Morusin on In Vivo Secretion and In Vitro Production of Airway MUC5AC Mucin.

Journal: Tuberculosis and respiratory diseases

Published: February 12, 2014

Progression-free survival: an important prognostic marker for long-term survival of small cell lung cancer.

Progression-free survival: an important prognostic marker for long-term survival of small cell lung cancer.

Journal: Tuberculosis and respiratory diseases

Published: January 24, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026